TGF-β and restenosis revisited: A smad link

Journal of Surgical Research

Volumn 167, Issue 2, 2011, Pages 287-297

  Suwanabol, Pasithorn A ^a   Kent, K Craig ^a   Liu, Bo ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

angioplasty; intimal hyperplasia; restenosis; Smad; transforming growth factor beta (TGF )

Indexed keywords

ACETYLSALICYLIC ACID; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTERIAL WALL THICKNESS; ARTERY INJURY; EXPERIMENTAL RABBIT; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RESTENOSIS; REVIEW; UPREGULATION;

ANIMALS; CORONARY RESTENOSIS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUNICA INTIMA;

EID: 79954606150     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.12.020     Document Type: Review

References (101)

1. J. Massague The transforming growth factor-β family Annu Rev Cell Biol 6 1990 597
2. J.A. Madri, M.A. Reidy, and O. Kocher Endothelial cell behavior after denudation injury is modulated by transforming growth factor-β1 and fibronectin Lab Invest 60 1989 755
3. M.W. Majesky, V. Lindner, and D.R. Twardzik Production of transforming growth factor β 1 during repair of arterial injury J Clin Invest 88 1991 904
4. S. Nikol, J.M. Isner, and J.G. Pickering Expression of transforming growth factor-β 1 is increased in human vascular restenosis lesions J Clin Invest 90 1992 1582
5. C. Yutani, H. Ishibashi-Ueda, and T. Suzuki Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis Cardiology 92 1999 171
6. J. Chamberlain, J. Gunn, and S.E. Francis TGF-β is active, and correlates with activators of TGF-β, following porcine coronary angioplasty Cardiovasc Res 50 2001 125
7. E.G. Nabel, L. Shum, and V.J. Pompili Direct transfer of transforming growth factor β 1 gene into arteries stimulates fibrocellular hyperplasia Proc Natl Acad Sci U S A 90 1993 10759
8. T. Kanzaki, K. Tamura, and K. Takahashi In vivo effect of TGF-β 1. Enhanced intimal thickening by administration of TGF-β 1 in rabbit arteries injured with a balloon catheter Arterioscler Thromb Vasc Biol 15 1995 1951
9. R.A. Wolff, R.L. Malinowski, and N.S. Heaton Transforming growth factor-β1 antisense treatment of rat vein grafts reduces the accumulation of collagen and increases the accumulation of h-caldesmon J Vasc Surg 43 2006 1028
10. P.A. Kingston, S. Sinha, and C.E. Appleby Adenovirus-mediated gene transfer of transforming growth factor-β3, but not transforming growth factor-β1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty Circulation 108 2003 2819
11. Y.G. Wolf, L.M. Rasmussen, and E. Ruoslahti Antibodies against transforming growth factor-β 1 suppress intimal hyperplasia in a rat model J Clin Invest 93 1994 1172
12. K. Yamamoto, R. Morishita, and N. Tomita Ribozyme oligonucleotides against transforming growth factor-β inhibited neointimal formation after vascular injury in rat model: Potential application of ribozyme strategy to treat cardiovascular disease Circulation 102 2000 1308
13. J.D. Smith, S.R. Bryant, and L.L. Couper Soluble transforming growth factor-β type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth Circ Res 84 1999 1212
14. P.A. Kingston, S. Sinha, and A. David Adenovirus-mediated gene transfer of a secreted transforming growth factor-β type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition Circulation 104 2001 2595
15. A. Mekontso-Dessap, M. Kirsch, and C. Guignambert Vascular-wall remodeling of 3 human bypass vessels: Organ culture and smooth muscle cell properties J Thorac Cardiovasc Surg 131 2006 651
16. S. Glagov, E. Weisenberg, and C.K. Zarins Compensatory enlargement of human atherosclerotic coronary arteries N Engl J Med 316 1987 1371
17. M.G. Bond, M.R. Adams, and B.C. Bullock Complicating factors in evaluating coronary artery atherosclerosis Artery 9 1981 21
18. Y. Shi, J.E. O'Brien Jr., and A. Fard Transforming growth factor-β 1 expression and myofibroblast formation during arterial repair Arterioscler Thromb Vasc Biol 16 1996 1298
19. J. Ghosh, M.O. Murphy, and N. Turner The role of transforming growth factor β1 in the vascular system Cardiovasc Pathol 14 2005 28
20. B. Lopez, A. Gonzalez, and N. Varo Biochemical assessment of myocardial fibrosis in hypertensive heart disease Hypertension 38 2001 1222
21. M.E. Mercado-Pimentel, and R.B. Runyan Multiple transforming growth factor-β isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart Cells Tissues Organs 185 2007 146
22. R. Derynck, and Y.E. Zhang Smad-dependent and Smad-independent pathways in TGF-β family signalling Nature 425 2003 577
23. M. Ruiz-Ortega, J. Rodriguez-Vita, and E. Sanchez-Lopez TGF-β signaling in vascular fibrosis Cardiovasc Res 74 2007 196
24. I. Sehgal, and T.C. Thompson Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-β1 in human prostate cancer cell lines Mol Biol Cell 10 1999 407
25. M. Wang, D. Zhao, and G. Spinetti Matrix metalloproteinase 2 activation of transforming growth factor-β1 (TGF-β1) and TGF-β1-type II receptor signaling within the aged arterial wall Arterioscler Thromb Vasc Biol 26 2006 1503
26. M.J. Goumans, Z. Liu, and P. ten Dijke TGF-β signaling in vascular biology and dysfunction Cell Res 19 2009 116
27. X.F. Wang, H.Y. Lin, and E. Ng-Eaton Expression cloning and characterization of the TGF-β type III receptor Cell 67 1991 797
28. S.P. Oh, T. Seki, and K.A. Goss Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis Proc Natl Acad Sci U S A 97 2000 2626
29. T. Seki, K.H. Hong, and S.P. Oh Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development Lab Invest 86 2006 116
30. J.S. Kang, C. Liu, and R. Derynck New regulatory mechanisms of TGF-β receptor function Trends Cell Biol 19 2009 385
31. M.J. Goumans, and C. Mummery Functional analysis of the TGF-β receptor/Smad pathway through gene ablation in mice Int J Dev Biol 44 2000 253
32. M.K. Lee, C. Pardoux, and M.C. Hall TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA EMBO J 26 2007 3957
33. A.J. Galliher, and W.P. Schiemann Src phosphorylates Tyr284 in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion Cancer Res 67 2007 3752
34. P. Kavsak, R.K. Rasmussen, and C.G. Causing Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-β receptor for degradation Mol Cell 6 2000 1365
35. M. Yamashita, S.X. Ying, and G.M. Zhang Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation Cell 121 2005 101
36. J.S. Kang, E.F. Saunier, and R.J. Akhurst The type I TGF-β receptor is covalently modified and regulated by sumoylation Nat Cell Biol 10 2008 654
37. T. Chen, D. Carter, and L. Garrigue-Antar Transforming growth factor β type I receptor kinase mutant associated with metastatic breast cancer Cancer Res 58 1998 4805
38. S. Ross, and C.S. Hill How the Smads regulate transcription Int J Biochem Cell Biol 40 2008 383
39. J. Massague, and Y.G. Chen Controlling TGF-β signaling Genes Dev 14 2000 627
40. K. Yagi, D. Goto, and T. Hamamoto Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3 J Biol Chem 274 1999 703
41. M.B. Datto, J.P. Frederick, and L. Pan Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction Mol Cell Biol 19 1999 2495
42. K. Miyazono, P. ten Dijke, and C.H. Heldin TGF-β signaling by Smad proteins Adv Immunol 75 2000 115
43. S. Itoh, and P. ten Dijke Negative regulation of TGF-β receptor/Smad signal transduction Curr Opin Cell Biol 19 2007 176
44. W. Shi, C. Sun, and B. He GADD34-PP1c recruited by Smad7 dephosphorylates TGF-β type I receptor J Cell Biol 164 2004 291
45. L. Izzi, and L. Attisano Ubiquitin-dependent regulation of TGF-β signaling in cancer Neoplasia 8 2006 677
46. T. Yamaguchi, A. Kurisaki, and N. Yamakawa FKBP12 functions as an adaptor of the Smad7-Smurf1 complex on activin type I receptor J Mol Endocrinol 36 2006 569
47. M. Kowanetz, P. Lonn, M. Vanlandewijck, K. Kowanetz, C.H. Heldin, and A. Moustakas TGF-β induces SIK to negatively regulate type I receptor kinase signaling J Cell Biol 182 2008 655
48. T. Tsukazaki, T.A. Chiang, and A.F. Davison SARA, a FYVE domain protein that recruits Smad2 to the TGF-β receptor Cell 95 1998 779
49. G.M. Di Guglielmo, C. Le Roy, and A.F. Goodfellow Distinct endocytic pathways regulate TGF-β receptor signalling and turnover Nat Cell Biol 5 2003 410
50. X. Guo, A. Ramirez, and D.S. Waddell Axin and GSK3- control Smad3 protein stability and modulate TGF-signaling Genes Dev 22 2008 106
51. M.E. Maurer, and J.A. Cooper The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH J Cell Sci 119 2006 4235
52. J. Massague, and D. Wotton Transcriptional control by the TGF-β/Smad signaling system EMBO J 19 2000 1745
53. M. Huse, Y.G. Chen, and J. Massague Crystal structure of the cytoplasmic domain of the type I TGF-β receptor in complex with FKBP12 Cell 96 1999 425
54. D. Onichtchouk, Y.G. Chen, and R. Dosch Silencing of TGF-β signalling by the pseudoreceptor BAMBI Nature 401 1999 480
55. X. Chen, E. Weisberg, and V. Fridmacher Smad4 and FAST-1 in the assembly of activin-responsive factor Nature 389 1997 85
56. X.H. Feng, Y. Zhang, and R.Y. Wu The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-β-induced transcriptional activation Genes Dev 12 1998 2153
57. R. Janknecht, N.J. Wells, and T. Hunter TGF-β-stimulated cooperation of smad proteins with the coactivators CBP/p300 Genes Dev 12 1998 2114
58. C. Pouponnot, L. Jayaraman, and J. Massague Physical and functional interaction of SMADs and p300/CBP J Biol Chem 273 1998 22865
59. X. Shen, P.P. Hu, and N.T. Liberati TGF-β-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein Mol Biol Cell 9 1998 3309
60. F. Zhang, S. Tsai, and K. Kato Transforming growth factor-β promotes recruitment of bone marrow cells and bone marrow-derived mesenchymal stem cells through stimulation of MCP-1 production in vascular smooth muscle cells J Biol Chem 284 2009 17564
61. A. Moustakas, and C.H. Heldin Non-Smad TGF-β signals J Cell Sci 118 2005 3573
62. M. Kretzschmar, J. Doody, and J. Massague Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 Nature 389 1997 618
63. J.D. Brown, M.R. DiChiara, and K.R. Anderson MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells J Biol Chem 274 1999 8797
64. M.E. Engel, M.A. McDonnell, and B.K. Law Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription J Biol Chem 274 1999 37413
65. Y. Zhang, X.H. Feng, and R. Derynck Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription Nature 394 1998 909
66. C. Wong, E.M. Rougier-Chapman, and J.P. Frederick Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor β Mol Cell Biol 19 1999 1821
67. J.P. Sluijter, R.E. Verloop, and W.P. Pulskens Involvement of furin-like proprotein convertases in the arterial response to injury Cardiovasc Res 68 2005 136
68. R.J. LeClair, T. Durmus, and Q. Wang Cthrc1 is a novel inhibitor of transforming growth factor-β signaling and neointimal lesion formation Circ Res 100 2007 826
69. W. Zeng, W. Chen, and X. Leng Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-β/Smad signaling pathway in rabbits Biochem Biophys Res Commun 389 2009 138
70. S. Tsai, S.T. Hollenbeck, and E.J. Ryer TGF-β through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation Am J Physiol Heart Circ Physiol 297 2009 H540
71. R. Kundi, S.T. Hollenbeck, and D. Yamanouchi Arterial gene transfer of the TGF-β signalling protein Smad3 induces adaptive remodelling following angioplasty: A role for CTGF Cardiovasc Res 84 2009 326
72. R.S. Edlin, S. Tsai, and D. Yamanouchi Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation J Vasc Surg 49 2009 1289
73. A.B. Roberts, A. Russo, and A. Felici Smad3: A key player in pathogenetic mechanisms dependent on TGF-β Ann N Y Acad Sci 995 2003 1
74. A. Leask Abraham DJ TGF-β signaling and the fibrotic response FASEB J 18 2004 816
75. L.B. Lopes, E.J. Furnish, and P. Komalavilas Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-β1-induced CTGF expression in keloid fibroblasts J Invest Dermatol 129 2009 590
76. Z. Jiang, P. Yu, and M. Tao TGF-β- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling Am J Physiol Heart Circ Physiol 293 2007 H482
77. S. Itoh, M. Thorikay, and M. Kowanetz Elucidation of Smad requirement in transforming growth factor-β type I receptor-induced responses J Biol Chem 278 2003 3751
78. J. Rodriguez-Vita, E. Sanchez-Lopez, and V. Esteban Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-β-independent mechanism Circulation 111 2005 2509
79. E.J. Ryer, R.P. Hom, and K. Sakakibara PKCdelta is necessary for Smad3 expression and transforming growth factor β-induced fibronectin synthesis in vascular smooth muscle cells Arterioscler Thromb Vasc Biol 26 2006 780
80. C.M. Mallawaarachchi, P.L. Weissberg, and R.C. Siow Smad7 gene transfer attenuates adventitial cell migration and vascular remodeling after balloon injury Arterioscler Thromb Vasc Biol 25 2005 1383
81. K. Kobayashi, K. Yokote, and M. Fujimoto Targeted disruption of TGF-β-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury Circ Res 96 2005 904
82. M. Sata, A. Saiura, and A. Kunisato Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis Nat Med 8 2002 403
83. S. Tsai, J. Butler, and S. Rafii The role of progenitor cells in the development of intimal hyperplasia J Vasc Surg 49 2009 502
84. S. Chen, M. Crawford, and R.M. Day RhoA modulates Smad signaling during transforming growth factor-β-induced smooth muscle differentiation J Biol Chem 281 2006 1765
85. H. Imamura, T. Ohta, and K. Tsunetoshi Transdifferentiation of bone marrow-derived endothelial progenitor cells into the smooth muscle cell lineage mediated by tansforming growth factor-β1 Atherosclerosis 211 2010 114
86. M.W. Feinberg, K. Shimizu, and M. Lebedeva Essential role for Smad3 in regulating MCP-1 expression and vascular inflammation Circ Res 94 2004 601
87. D.J. Grainger, P.R. Kemp, and J.C. Metcalfe The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis Nat Med 1 1995 74
88. H. Tashiro, H. Shimokawa, and K. Sadamatu Prognostic significance of plasma concentrations of transforming growth factor-β in patients with coronary artery disease Coron Artery Dis 13 2002 139
89. M. Erren, H. Reinecke, and R. Junker Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries Arterioscler Thromb Vasc Biol 19 1999 2355
90. S. Stefoni, G. Cianciolo, and G. Donati Low TGF-β1 serum levels are a risk factor for atherosclerosis disease in ESRD patients Kidney Int 61 2002 324
91. Z. Mallat, A. Gojova, and C. Marchiol-Fournigault Inhibition of transforming growth factor-β signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice Circ Res 89 2001 930
92. E. Lutgens, M. Gijbels, and M. Smook Transforming growth factor-β mediates balance between inflammation and fibrosis during plaque progression Arterioscler Thromb Vasc Biol 22 2002 975
93. M. Tian, and W.P. Schiemann The TGF-β paradox in human cancer: An update Future Oncol 5 2009 259
94. L. Yang TGF-β and cancer metastasis: An inflammation link Cancer Metastasis Rev 29 2010 263
95. A. Pfeiffer, K. Middelberg-Bisping, and C. Drewes Elevated plasma levels of transforming growth factor-β 1 in NIDDM Diabetes Care 19 1996 1113
96. C. Herder, A. Zierer, and W. Koenig Transforming growth factor-β1 and incident type 2 diabetes: Results from the MONICA/KORA case-cohort study, 1984-2002 Diabetes Care 32 2009 1921
97. W.A. Border, T. Yamamoto, and N.A. Noble Transforming growth factor β in diabetic nephropathy Diabetes Metab Rev 12 1996 309
98. W.B. Reeves, and T.E. Andreoli Transforming growth factor β contributes to progressive diabetic nephropathy Proc Natl Acad Sci U S A 97 2000 7667
99. C. Mur, J. Claria, and S. Rodela Cigarette smoke concentrate increases 8-epi-PGF2alpha and TGF-β1 secretion in rat mesangial cells Life Sci 75 2004 611
100. G. Carrieri, E. Marzi, and F. Olivieri The G/C915 polymorphism of transforming growth factor β1 is associated with human longevity: A study in Italian centenarians Aging Cell 3 2004 443
101. B. Juraskova, C. Andrys, and I. Holmerova Transforming growth factor β and soluble endoglin in the healthy senior and in Alzheimer ' s disease patients J Nutr Health Aging 14 2010 758